{
  "company": "CIPLA",
  "report_date": "August 08, 2018",
  "filename": "CIPLA_transcript_Aug_2018.pdf",
  "quarter": "Q1",
  "fiscal_year": "2019",
  "management_team": [
    "MR. UMANG VOHRA - MD & GLOBAL CEO, CIPLA",
    "MR. KEDAR UPADHYE - GLOBAL CFO, CIPLA",
    "MR. NAVEEN BANSAL - INVESTOR RELATIONS TEAM,",
    "UMANG VOHRA - MD & GLOBAL CEO, CIPLA",
    "KEDAR UPADHYE - GLOBAL CFO, CIPLA",
    "NAVEEN BANSAL - INVESTOR RELATIONS TEAM,"
  ],
  "moderator": "MR",
  "analysts": [
    {
      "name": "Prakash Agarwal",
      "firm": "Axis Capital"
    },
    {
      "name": "Neha Manpuria",
      "firm": "JP Morgan"
    },
    {
      "name": "Anubhav Agarwal",
      "firm": "Credit Suisse"
    },
    {
      "name": "Nitin Agarwal",
      "firm": "IDFC"
    },
    {
      "name": "Sameer Baisiwala",
      "firm": "Morgan \nStanley"
    },
    {
      "name": "Abhishek Sharma",
      "firm": "IIFL"
    },
    {
      "name": "Charulata Gaidhani",
      "firm": "Dalal & \nBroacha"
    },
    {
      "name": "Purvi Shah",
      "firm": "Sharekhan"
    },
    {
      "name": "Vishal Manchanda",
      "firm": "Nirmal \nBang"
    },
    {
      "name": "Chirag Dagli",
      "firm": "HDFC Asset \nManagement"
    },
    {
      "name": "Prashant Nair",
      "firm": "Citi Group"
    },
    {
      "name": "Surya Patra",
      "firm": "PhillipCapital"
    },
    {
      "name": "Tushar Manudhane",
      "firm": "Motilal Oswal \nSecurities"
    },
    {
      "name": "Shyam Srinivasan",
      "firm": "Goldman Sachs"
    }
  ],
  "qa_segments": [],
  "key_financial_metrics": {
    "sales_inr_crores": "1075",
    "growth_percentage": "12"
  },
  "business_highlights": [
    "launched five new products during the quarter.",
    "partnership with Eli \nLilly for launching BASAGLAR which is the insulin glargine injection in India.",
    "partnership with Roche strengthening our oncology portfolio with the launch of three \nmonoclonal antibodies.",
    "acquired business has been growing over 25% in an OTC \nsegment and is growing 300 basis points higher than market.",
    "acquired business and now have access to a local manufacturing \nfacility as well."
  ],
  "extraction_metadata": {
    "extraction_date": "2025-08-03T01:08:50.186364",
    "source_file": "data\\cipla\\CIPLA_transcript_Aug_2018.pdf",
    "text_length": 52161,
    "extraction_method": "PyMuPDF + Regex parsing + Filename analysis"
  }
}